PUBLISHER: KBV Research | PRODUCT CODE: 1309622
PUBLISHER: KBV Research | PRODUCT CODE: 1309622
North America Specialty Generics Market Size, Share & Industry Trends Analysis Report By Type, By Application, By End Use, By Country and Growth Forecast, 2023 - 2030
The North America Specialty Generics Market would witness market growth of 9.0% CAGR during the forecast period (2023-2030).
The complex or high-end specialty generics are generic equivalents of drugs. However, they follow different regulatory processes. The prevalence of many life-threatening diseases, such as cancer, Multiple Sclerosis (MS), and HIV, has increased regionally, which is expected to result in a rise in the need for specialized pharmaceuticals. For a variety of medication delivery methods, including intravenous, intradermal, intramuscular, intraperitoneal, subcutaneous, and others, specialty generic injectables are used to treat ailments ranging from cancer to autoimmune disorders.
During drug injection, a chemical is injected into the bloodstream using a hollow hypodermic needle. Oncology, autoimmune disorders, infectious diseases, and other indications are treated using specialty generics, which are sold through a variety of channels, including specialty pharmacies, retail pharmacies, and hospital pharmacies. Due to specific production needs, greater capital costs, and generally lower quantities as a result of a smaller patient population, specialized generics have a more competitive market than regular generics. This leads to better profits than standard generics and a lesser price drop relative to branded medicine. Since specialty generics are given by unique players, they typically require prior authorization in the market and special handling, administration, and monitoring.
The American Cancer Society reports that in 2018, there were roughly 154,050 lung cancer-related deaths in the United States, with an estimated 234,030 new cases of lung cancer being diagnosed. According to the American Lung Association, 541,000 Americans have received a lung cancer diagnosis at some time in their lives. The majority of patients have received a lung cancer diagnosis during the last five years. Each year, non-small cell lung cancer (NSCLC) is treated in tens of thousands of Americans. The market is expected to grow as a result of lung cancer's increasing prevalence. Because of the increase in cancer incidence, there is a greater need for products such as specialty generics, which boosts the regional market.
The US market dominated the North America Specialty Generics Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $33,131.9 million by 2030. The Canada market is exhibiting a CAGR of 11.5% during (2023 - 2030). Additionally, The Mexico market would witness a CAGR of 10.5% during (2023 - 2030).
Based on Type, the market is segmented into Injectables, Oral Drugs, and Others. Based on Application, the market is segmented into Inflammatory conditions, Multiple sclerosis, Hepatitis C, Oncology, and Others. Based on End Use, the market is segmented into Specialty Pharmacy, Retail Pharmacy, and Hospital Pharmacy. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Teva Pharmaceuticals Industries Ltd., Novartis AG, Hikma Pharmaceuticals PLC, Sun Pharmaceutical Industries Ltd., Fresenius SE & Co. KGaA, Dr. Reddy's Laboratories Ltd., Mallinckrodt PLC, Bausch Health Companies, Inc., Viatris, Inc. and Apotex, Inc.
Scope of the Study
Market Segments covered in the Report:
By Type
- Injectables
- Oral Drugs
- Others
By Application
- Inflammatory conditions
- Multiple sclerosis
- Hepatitis C
- Oncology
- Others
By End Use
- Specialty Pharmacy
- Retail Pharmacy
- Hospital Pharmacy
By Country
- US
- Canada
- Mexico
- Rest of North America
Companies Profiled
- Teva Pharmaceuticals Industries Ltd.
- Novartis AG
- Hikma Pharmaceuticals PLC
- Sun Pharmaceutical Industries Ltd.
- Fresenius SE & Co. KGaA
- Dr. Reddy's Laboratories Ltd.
- Mallinckrodt PLC
- Bausch Health Companies, Inc.
- Viatris, Inc.
- Apotex, Inc.
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 North America Specialty Generics Market, by Type
- 1.4.2 North America Specialty Generics Market, by Application
- 1.4.3 North America Specialty Generics Market, by End Use
- 1.4.4 North America Specialty Generics Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market Composition and Scenario
- 2.1.1 Overview
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
- 3.1 KBV Cardinal Matrix
- 3.2 Recent Industry Wide Strategic Developments
- 3.2.1 Partnerships, Collaborations and Agreements
- 3.2.2 Product Launches and Product Expansions
- 3.2.3 Acquisition and Mergers
- 3.2.4 Approvals and Trials
- 3.3 Top Winning Strategies
- 3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
- 3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2020, May - 2023, Jan) Leading Players
Chapter 4. North America Specialty Generics Market by Type
- 4.1 North America Injectables Market by Country
- 4.2 North America Oral Drugs Market by Country
- 4.3 North America Others Market by Country
Chapter 5. North America Specialty Generics Market by Application
- 5.1 North America Inflammatory conditions Market by Country
- 5.2 North America Multiple sclerosis Market by Country
- 5.3 North America Hepatitis C Market by Country
- 5.4 North America Oncology Market by Country
- 5.5 North America Others Market by Country
Chapter 6. North America Specialty Generics Market by End Use
- 6.1 North America Specialty Pharmacy Market by Country
- 6.2 North America Retail Pharmacy Market by Country
- 6.3 North America Hospital Pharmacy Market by Country
Chapter 7. North America Specialty Generics Market by Country
- 7.1 US Specialty Generics Market
- 7.1.1 US Specialty Generics Market by Type
- 7.1.2 US Specialty Generics Market by Application
- 7.1.3 US Specialty Generics Market by End Use
- 7.2 Canada Specialty Generics Market
- 7.2.1 Canada Specialty Generics Market by Type
- 7.2.2 Canada Specialty Generics Market by Application
- 7.2.3 Canada Specialty Generics Market by End Use
- 7.3 Mexico Specialty Generics Market
- 7.3.1 Mexico Specialty Generics Market by Type
- 7.3.2 Mexico Specialty Generics Market by Application
- 7.3.3 Mexico Specialty Generics Market by End Use
- 7.4 Rest of North America Specialty Generics Market
- 7.4.1 Rest of North America Specialty Generics Market by Type
- 7.4.2 Rest of North America Specialty Generics Market by Application
- 7.4.3 Rest of North America Specialty Generics Market by End Use
Chapter 8. Company Profiles
- 8.1 Teva Pharmaceutical Industries Ltd.
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Regional Analysis
- 8.1.4 Research & Development Expenses
- 8.1.5 Recent strategies and developments:
- 8.1.5.1 Partnerships, Collaborations, and Agreements:
- 8.1.5.2 Product Launches and Product Expansions:
- 8.2 Novartis AG
- 8.2.1 Company Overview
- 8.2.2 Financial Analysis
- 8.2.3 Segmental and Regional Analysis
- 8.2.4 Research & Development Expense
- 8.2.5 Recent strategies and developments:
- 8.2.5.1 Partnerships, Collaborations, and Agreements:
- 8.2.5.2 Acquisition and Mergers:
- 8.3 Hikma Pharmaceuticals PLC
- 8.3.1 Company Overview
- 8.3.2 Financial Analysis
- 8.3.3 Segmental and Regional Analysis
- 8.3.4 Research & Development Expenses
- 8.3.5 Recent strategies and developments:
- 8.3.5.1 Partnerships, Collaborations, and Agreements:
- 8.3.5.2 Product Launches and Product Expansions:
- 8.4 Sun Pharmaceutical Industries Ltd.
- 8.4.1 Company Overview
- 8.4.2 Financial Analysis
- 8.4.3 Regional Analysis
- 8.4.4 Research & Development Expenses
- 8.4.5 Recent strategies and developments:
- 8.4.5.1 Partnerships, Collaborations, and Agreements:
- 8.4.5.2 Product Launches and Product Expansions:
- 8.5 Fresenius SE & Co. KGaA
- 8.5.1 Company Overview
- 8.5.2 Financial Analysis
- 8.5.3 Segmental and Regional Analysis
- 8.5.4 Research & Development Expenses
- 8.5.5 Recent strategies and developments:
- 8.5.5.1 Acquisition and Mergers:
- 8.6 Dr. Reddy's Laboratories Ltd.
- 8.6.1 Company Overview
- 8.6.2 Financial Analysis
- 8.6.3 Segmental and Regional Analysis
- 8.6.4 Research & Development Expense
- 8.6.5 Recent strategies and developments:
- 8.6.5.1 Product Launches and Product Expansions:
- 8.7 Mallinckrodt PLC
- 8.7.1 Company Overview
- 8.7.2 Financial Analysis
- 8.7.3 Segmental and Regional Analysis
- 8.7.4 Research & Development Expense
- 8.7.5 Recent strategies and developments:
- 8.7.5.1 Partnerships, Collaborations, and Agreements:
- 8.8 Bausch Health Companies, Inc
- 8.8.1 Company Overview
- 8.8.2 Financial Analysis
- 8.8.3 Segmental and Regional Analysis
- 8.8.4 Research & Development Expense
- 8.8.5 Recent strategies and developments:
- 8.8.5.1 Partnerships, Collaborations, and Agreements:
- 8.9 Viatris, Inc.
- 8.9.1 Company Overview
- 8.9.2 Financial Analysis
- 8.9.3 Segmental Analysis
- 8.9.4 Research & Development Expense
- 8.9.5 Recent strategies and developments:
- 8.9.5.1 Partnerships, Collaborations, and Agreements:
- 8.10. Apotex, Inc.
- 8.10.1 Company Overview
LIST OF TABLES
- TABLE 1 North America Specialty Generics Market, 2019 - 2022, USD Million
- TABLE 2 North America Specialty Generics Market, 2023 - 2030, USD Million
- TABLE 3 Partnerships, Collaborations and Agreements- Specialty Generics Market
- TABLE 4 Product Launches And Product Expansions- Specialty Generics Market
- TABLE 5 Acquisition and Mergers- Specialty Generics Market
- TABLE 6 Approvals and Trials- Specialty Generics Market
- TABLE 7 North America Specialty Generics Market by Type, 2019 - 2022, USD Million
- TABLE 8 North America Specialty Generics Market by Type, 2023 - 2030, USD Million
- TABLE 9 North America Injectables Market by Country, 2019 - 2022, USD Million
- TABLE 10 North America Injectables Market by Country, 2023 - 2030, USD Million
- TABLE 11 North America Oral Drugs Market by Country, 2019 - 2022, USD Million
- TABLE 12 North America Oral Drugs Market by Country, 2023 - 2030, USD Million
- TABLE 13 North America Others Market by Country, 2019 - 2022, USD Million
- TABLE 14 North America Others Market by Country, 2023 - 2030, USD Million
- TABLE 15 North America Specialty Generics Market by Application, 2019 - 2022, USD Million
- TABLE 16 North America Specialty Generics Market by Application, 2023 - 2030, USD Million
- TABLE 17 North America Inflammatory conditions Market by Country, 2019 - 2022, USD Million
- TABLE 18 North America Inflammatory conditions Market by Country, 2023 - 2030, USD Million
- TABLE 19 North America Multiple sclerosis Market by Country, 2019 - 2022, USD Million
- TABLE 20 North America Multiple sclerosis Market by Country, 2023 - 2030, USD Million
- TABLE 21 North America Hepatitis C Market by Country, 2019 - 2022, USD Million
- TABLE 22 North America Hepatitis C Market by Country, 2023 - 2030, USD Million
- TABLE 23 North America Oncology Market by Country, 2019 - 2022, USD Million
- TABLE 24 North America Oncology Market by Country, 2023 - 2030, USD Million
- TABLE 25 North America Others Market by Country, 2019 - 2022, USD Million
- TABLE 26 North America Others Market by Country, 2023 - 2030, USD Million
- TABLE 27 North America Specialty Generics Market by End Use, 2019 - 2022, USD Million
- TABLE 28 North America Specialty Generics Market by End Use, 2023 - 2030, USD Million
- TABLE 29 North America Specialty Pharmacy Market by Country, 2019 - 2022, USD Million
- TABLE 30 North America Specialty Pharmacy Market by Country, 2023 - 2030, USD Million
- TABLE 31 North America Retail Pharmacy Market by Country, 2019 - 2022, USD Million
- TABLE 32 North America Retail Pharmacy Market by Country, 2023 - 2030, USD Million
- TABLE 33 North America Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
- TABLE 34 North America Hospital Pharmacy Market by Country, 2023 - 2030, USD Million
- TABLE 35 North America Specialty Generics Market by Country, 2019 - 2022, USD Million
- TABLE 36 North America Specialty Generics Market by Country, 2023 - 2030, USD Million
- TABLE 37 US Specialty Generics Market, 2019 - 2022, USD Million
- TABLE 38 US Specialty Generics Market, 2023 - 2030, USD Million
- TABLE 39 US Specialty Generics Market by Type, 2019 - 2022, USD Million
- TABLE 40 US Specialty Generics Market by Type, 2023 - 2030, USD Million
- TABLE 41 US Specialty Generics Market by Application, 2019 - 2022, USD Million
- TABLE 42 US Specialty Generics Market by Application, 2023 - 2030, USD Million
- TABLE 43 US Specialty Generics Market by End Use, 2019 - 2022, USD Million
- TABLE 44 US Specialty Generics Market by End Use, 2023 - 2030, USD Million
- TABLE 45 Canada Specialty Generics Market, 2019 - 2022, USD Million
- TABLE 46 Canada Specialty Generics Market, 2023 - 2030, USD Million
- TABLE 47 Canada Specialty Generics Market by Type, 2019 - 2022, USD Million
- TABLE 48 Canada Specialty Generics Market by Type, 2023 - 2030, USD Million
- TABLE 49 Canada Specialty Generics Market by Application, 2019 - 2022, USD Million
- TABLE 50 Canada Specialty Generics Market by Application, 2023 - 2030, USD Million
- TABLE 51 Canada Specialty Generics Market by End Use, 2019 - 2022, USD Million
- TABLE 52 Canada Specialty Generics Market by End Use, 2023 - 2030, USD Million
- TABLE 53 Mexico Specialty Generics Market, 2019 - 2022, USD Million
- TABLE 54 Mexico Specialty Generics Market, 2023 - 2030, USD Million
- TABLE 55 Mexico Specialty Generics Market by Type, 2019 - 2022, USD Million
- TABLE 56 Mexico Specialty Generics Market by Type, 2023 - 2030, USD Million
- TABLE 57 Mexico Specialty Generics Market by Application, 2019 - 2022, USD Million
- TABLE 58 Mexico Specialty Generics Market by Application, 2023 - 2030, USD Million
- TABLE 59 Mexico Specialty Generics Market by End Use, 2019 - 2022, USD Million
- TABLE 60 Mexico Specialty Generics Market by End Use, 2023 - 2030, USD Million
- TABLE 61 Rest of North America Specialty Generics Market, 2019 - 2022, USD Million
- TABLE 62 Rest of North America Specialty Generics Market, 2023 - 2030, USD Million
- TABLE 63 Rest of North America Specialty Generics Market by Type, 2019 - 2022, USD Million
- TABLE 64 Rest of North America Specialty Generics Market by Type, 2023 - 2030, USD Million
- TABLE 65 Rest of North America Specialty Generics Market by Application, 2019 - 2022, USD Million
- TABLE 66 Rest of North America Specialty Generics Market by Application, 2023 - 2030, USD Million
- TABLE 67 Rest of North America Specialty Generics Market by End Use, 2019 - 2022, USD Million
- TABLE 68 Rest of North America Specialty Generics Market by End Use, 2023 - 2030, USD Million
- TABLE 69 Key Information - Teva Pharmaceuticals Industries Ltd.
- TABLE 70 Key Information - Novartis AG
- TABLE 71 Key Information - Hikma Pharmaceuticals PLC
- TABLE 72 Key Information - Sun Pharmaceutical Industries Ltd.
- TABLE 73 key information - Fresenius SE & Co. KGaA
- TABLE 74 key information - Dr. Reddy's Laboratories Ltd.
- TABLE 75 Key information - Mallinckrodt PLC
- TABLE 76 key information - Bausch Health Companies, Inc.
- TABLE 77 key information - Viatris, Inc.
- TABLE 78 Key Information - Apotex, Inc.
List of Figures
- FIG 1 Methodology for the research
- FIG 2 KBV Cardinal Matrix
- FIG 3 Key Leading Strategies: Percentage Distribution (2019-2023)
- FIG 4 Key Strategic Move: (Product Launches and Product Expansions: 2020, May - 2023, Jan) Leading Players
- FIG 5 North America Specialty Generics Market Share by Type, 2022
- FIG 6 North America Specialty Generics Market Share by Type, 2030
- FIG 7 North America Specialty Generics Market by Type, 2019 - 2030, USD Million
- FIG 8 North America Specialty Generics Market share by Application, 2022
- FIG 9 North America Specialty Generics Market share by Application, 2030
- FIG 10 North America Specialty Generics Market by Application, 2019 - 2030, USD Million
- FIG 11 North America Specialty Generics Market share by End Use, 2022
- FIG 12 North America Specialty Generics Market share by End Use, 2030
- FIG 13 North America Specialty Generics Market by End Use, 2019 - 2030, USD Million
- FIG 14 North America Specialty Generics Market share by Country, 2022
- FIG 15 North America Specialty Generics Market share by Country, 2030
- FIG 16 North America Specialty Generics Market by Country, 2019 - 2030, USD Million
- FIG 17 Recent strategies and developments: Teva Pharmaceuticals Industries Ltd.
- FIG 18 Recent strategies and developments: Novartis AG
- FIG 19 Recent strategies and developments: Hikma Pharmaceuticals PLC
- FIG 20 Recent strategies and developments: Sun Pharmaceutical Industries Ltd.
